Nucleai is a precision medicine company that has developed an AI-powered pathology-based biomarker discovery platform to unlock the power of spatial biology from pathology images. Our platform, built and trained off large-scale proprietary datasets, leverages computer vision and deep neural networks to structure and characterize tissue and cell architecture in pathology images to identify spatial characteristics that predict response to therapy and inform treatment decision. Our vision is for every pathology image to run through the Nucleai platform, starting with pharma to augment biomarker discovery a